VOYA Investment Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
45,823
+22,151
| +94% | +$455K | ﹤0.01% | 1440 |
|
|
2026
Q1 | $455K | Sell |
23,672
-133
| -0.6% | -$2.65K | ﹤0.01% | 1759 |
|
|
2025
Q4 | $393K | Hold |
23,805
| – | – | ﹤0.01% | 1857 |
|
|
2025
Q3 | $346K | Sell |
23,805
-12,103
| -34% | -$174K | ﹤0.01% | 1927 |
|
|
2025
Q2 | $502K | Sell |
35,908
-15,103
| -30% | -$213K | ﹤0.01% | 1896 |
|
|
2025
Q1 | $693K | Sell |
51,011
-3,802
| -7% | -$72.8K | ﹤0.01% | 1721 |
|
|
2024
Q4 | $1.12M | Sell |
54,813
-2,991
| -5% | -$76.6K | ﹤0.01% | 1539 |
|
|
2024
Q3 | $1.68M | Sell |
57,804
-976
| -2% | -$24.2K | ﹤0.01% | 1397 |
|
|
2024
Q2 | $1.36M | Sell |
58,780
-161,858
| -73% | -$3.11M | ﹤0.01% | 1465 |
|
|
2024
Q1 | $4.53M | Sell |
220,638
-63,466
| -22% | -$1.19M | ﹤0.01% | 1049 |
|
|
2023
Q4 | $6.1M | Buy |
284,104
+19,488
| +7% | +$386K | 0.01% | 922 |
|
|
2023
Q3 | $5.46M | Buy |
264,616
+1,109
| +0.4% | +$28.1K | 0.01% | 934 |
|
|
2023
Q2 | $7.78M | Buy |
263,507
+71,779
| +37% | +$2.02M | 0.01% | 820 |
|
|
2023
Q1 | $4.42M | Buy |
191,728
+21,854
| +13% | +$601K | ﹤0.01% | 1035 |
|
|
2022
Q4 | $4.72M | Buy |
169,874
+3,938
| +2% | +$117K | 0.01% | 995 |
|
|
2022
Q3 | $5.09M | Sell |
165,936
-64,894
| -28% | -$2.11M | 0.01% | 943 |
|
|
2022
Q2 | $6.79M | Buy |
230,830
+99,848
| +76% | +$2.62M | 0.02% | 616 |
|
|
2022
Q1 | $4.21M | Buy |
130,982
+95,909
| +273% | +$3.3M | 0.01% | 887 |
|
|
2021
Q4 | $1.56M | Sell |
35,073
-518
| -1% | -$24.5K | ﹤0.01% | 1280 |
|
|
2021
Q3 | $1.8M | Sell |
35,591
-174
| -0.5% | -$9.81K | ﹤0.01% | 1227 |
|
|
2021
Q2 | $2.81M | Buy |
35,765
+8,192
| +30% | +$507K | 0.01% | 1060 |
|
|
2021
Q1 | $1.57M | Buy |
27,573
+223
| +0.8% | +$14.9K | ﹤0.01% | 1302 |
|
|
2020
Q4 | $2.29M | Buy |
27,350
+5,468
| +25% | +$331K | ﹤0.01% | 1079 |
|
|
2020
Q3 | $784K | Hold |
21,882
| – | – | ﹤0.01% | 1419 |
|
|
2020
Q2 | $529K | Sell |
21,882
-3,203
| -13% | -$75.3K | ﹤0.01% | 1630 |
|
|
2020
Q1 | $439K | Buy |
25,085
+1,788
| +8% | +$37.3K | ﹤0.01% | 1688 |
|
|
2019
Q4 | $406K | Buy |
23,297
+3,867
| +20% | +$64.4K | ﹤0.01% | 2004 |
|
|
2019
Q3 | $298K | Hold |
19,430
| – | – | ﹤0.01% | 2043 |
|
|
2019
Q2 | $403K | Buy |
19,430
+829
| +4% | +$18.6K | ﹤0.01% | 1917 |
|
|
2019
Q1 | $432K | Hold |
18,601
| – | – | ﹤0.01% | 1860 |
|
|
2018
Q4 | $384K | Buy |
18,601
+1,803
| +11% | +$32.7K | ﹤0.01% | 1883 |
|
|
2018
Q3 | $365K | Buy |
+16,798
| New | +$278K | ﹤0.01% | 2035 |
|
Other funds holding DNLI
VOYA Investment Management's DNLI Position: Q2 2026 in Review
VOYA Investment Management increased its Denali Therapeutics (DNLI) stake by 94% in Q2 2026, buying an estimated $455K and bringing the position to 45,823 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1440.
VOYA Investment Management first reported a position in DNLI in Q3 2018 and has held it in 32 quarters since. The position peaked at $7.78M in Q2 2023. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.
- VOYA Investment Management held 45,823 shares of Denali Therapeutics worth $1.18M as of Q2 2026.
- VOYA Investment Management bought 22,151 Denali Therapeutics shares in Q2 2026, an estimated $455K.
- Denali Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1440 holding.
- VOYA Investment Management first reported a position in Denali Therapeutics in Q3 2018 and has held it in 32 quarters since.
- VOYA Investment Management's Denali Therapeutics position peaked at $7.78M in Q2 2023.
- 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.
Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.